APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herceptin (Trastuzumab)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Herceptin (Trastuzumab) Market Analysis and Forecast 2026-2032

30 December 2025207 pages

Choose your research edition.

Industry ResearchHerceptin (Trastuzumab) Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Herceptin (Trastuzumab) Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Herceptin (Trastuzumab) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herceptin (Trastuzumab) Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Herceptin (Trastuzumab) Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Herceptin (Trastuzumab) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Herceptin (Trastuzumab) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Herceptin (Trastuzumab) include Teva Pharmaceutical, Novartis AG, Merck, Mylan, Pfizer, Amgen, Samsung Bioepis, Roche Diagnostics and Mundipharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Herceptin (Trastuzumab), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Herceptin (Trastuzumab), also provides the sales of main regions and countries. Of the upcoming market potential for Herceptin (Trastuzumab), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herceptin (Trastuzumab) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Herceptin (Trastuzumab) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Herceptin (Trastuzumab) sales, projected growth trends, production technology, application and end-user industry.

Herceptin (Trastuzumab) Segment by Company

Teva Pharmaceutical

Novartis AG

Merck

Mylan

Pfizer

Amgen

Samsung Bioepis

Roche Diagnostics

Mundipharma

Mabion

InvivoGen

Genentech

Celltrion

Bio-Techne

Biocon Limited

AryoGen Biopharma

Abnova Corporation

Herceptin (Trastuzumab) Segment by Type

Breast Cancer

Stomach Cancer

Others

Herceptin (Trastuzumab) Segment by Application

Hospital

Medical Center

Herceptin (Trastuzumab) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herceptin (Trastuzumab) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herceptin (Trastuzumab) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herceptin (Trastuzumab).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Herceptin (Trastuzumab) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Herceptin (Trastuzumab) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herceptin (Trastuzumab) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Herceptin (Trastuzumab) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Breast Cancer Major Manufacturers Table 3. Stomach Cancer Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global Herceptin (Trastuzumab) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Medical Center Major Manufacturers Table 8. Herceptin (Trastuzumab) Industry Trends Table 9. Herceptin (Trastuzumab) Industry Drivers Table 10. Herceptin (Trastuzumab) Industry Opportunities and Challenges Table 11. Herceptin (Trastuzumab) Industry Restraints Table 12. Global Herceptin (Trastuzumab) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Herceptin (Trastuzumab) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Herceptin (Trastuzumab) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2021-2026) Table 16. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2027-2032) Table 17. Global Herceptin (Trastuzumab) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Herceptin (Trastuzumab) Sales by Region (2021-2026) & (K Units) Table 19. Global Herceptin (Trastuzumab) Sales by Region (2027-2032) & (K Units) Table 20. Global Herceptin (Trastuzumab) Sales Market Share by Region (2021-2026) Table 21. Global Herceptin (Trastuzumab) Sales Market Share by Region (2027-2032) Table 22. Global Herceptin (Trastuzumab) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Herceptin (Trastuzumab) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Herceptin (Trastuzumab) Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Herceptin (Trastuzumab) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Herceptin (Trastuzumab) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Herceptin (Trastuzumab) Manufacturers, Product Type & Application Table 30. Global Herceptin (Trastuzumab) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Herceptin (Trastuzumab) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Herceptin (Trastuzumab) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2026) Table 37. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2027-2032) Table 38. Global Herceptin (Trastuzumab) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 40. Global Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 41. Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2026) Table 42. Global Herceptin (Trastuzumab) Sales Market Share by Type (2027-2032) Table 43. Global Herceptin (Trastuzumab) Price by Type (2021-2026) & (US$/Unit) Table 44. Global Herceptin (Trastuzumab) Price by Type (2027-2032) & (US$/Unit) Table 45. Global Herceptin (Trastuzumab) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2026) Table 49. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2027-2032) Table 50. Global Herceptin (Trastuzumab) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 52. Global Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 53. Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2026) Table 54. Global Herceptin (Trastuzumab) Sales Market Share by Application (2027-2032) Table 55. Global Herceptin (Trastuzumab) Price by Application (2021-2026) & (US$/Unit) Table 56. Global Herceptin (Trastuzumab) Price by Application (2027-2032) & (US$/Unit) Table 57. Teva Pharmaceutical Company Information Table 58. Teva Pharmaceutical Business Overview Table 59. Teva Pharmaceutical Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio Table 61. Teva Pharmaceutical Recent Development Table 62. Novartis AG Company Information Table 63. Novartis AG Business Overview Table 64. Novartis AG Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novartis AG Herceptin (Trastuzumab) Product Portfolio Table 66. Novartis AG Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Merck Herceptin (Trastuzumab) Product Portfolio Table 71. Merck Recent Development Table 72. Mylan Company Information Table 73. Mylan Business Overview Table 74. Mylan Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Mylan Herceptin (Trastuzumab) Product Portfolio Table 76. Mylan Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Pfizer Herceptin (Trastuzumab) Product Portfolio Table 81. Pfizer Recent Development Table 82. Amgen Company Information Table 83. Amgen Business Overview Table 84. Amgen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Amgen Herceptin (Trastuzumab) Product Portfolio Table 86. Amgen Recent Development Table 87. Samsung Bioepis Company Information Table 88. Samsung Bioepis Business Overview Table 89. Samsung Bioepis Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio Table 91. Samsung Bioepis Recent Development Table 92. Roche Diagnostics Company Information Table 93. Roche Diagnostics Business Overview Table 94. Roche Diagnostics Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio Table 96. Roche Diagnostics Recent Development Table 97. Mundipharma Company Information Table 98. Mundipharma Business Overview Table 99. Mundipharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Mundipharma Herceptin (Trastuzumab) Product Portfolio Table 101. Mundipharma Recent Development Table 102. Mabion Company Information Table 103. Mabion Business Overview Table 104. Mabion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mabion Herceptin (Trastuzumab) Product Portfolio Table 106. Mabion Recent Development Table 107. InvivoGen Company Information Table 108. InvivoGen Business Overview Table 109. InvivoGen Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. InvivoGen Herceptin (Trastuzumab) Product Portfolio Table 111. InvivoGen Recent Development Table 112. Genentech Company Information Table 113. Genentech Business Overview Table 114. Genentech Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Genentech Herceptin (Trastuzumab) Product Portfolio Table 116. Genentech Recent Development Table 117. Celltrion Company Information Table 118. Celltrion Business Overview Table 119. Celltrion Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Celltrion Herceptin (Trastuzumab) Product Portfolio Table 121. Celltrion Recent Development Table 122. Bio-Techne Company Information Table 123. Bio-Techne Business Overview Table 124. Bio-Techne Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Bio-Techne Herceptin (Trastuzumab) Product Portfolio Table 126. Bio-Techne Recent Development Table 127. Biocon Limited Company Information Table 128. Biocon Limited Business Overview Table 129. Biocon Limited Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Biocon Limited Herceptin (Trastuzumab) Product Portfolio Table 131. Biocon Limited Recent Development Table 132. AryoGen Biopharma Company Information Table 133. AryoGen Biopharma Business Overview Table 134. AryoGen Biopharma Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio Table 136. AryoGen Biopharma Recent Development Table 137. Abnova Corporation Company Information Table 138. Abnova Corporation Business Overview Table 139. Abnova Corporation Herceptin (Trastuzumab) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Abnova Corporation Herceptin (Trastuzumab) Product Portfolio Table 141. Abnova Corporation Recent Development Table 142. North America Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 143. North America Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 144. North America Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 145. North America Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 146. North America Herceptin (Trastuzumab) Sales Price by Type (2021-2026) & (US$/Unit) Table 147. North America Herceptin (Trastuzumab) Sales Price by Type (2027-2032) & (US$/Unit) Table 148. North America Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 149. North America Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 150. North America Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 151. North America Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 152. North America Herceptin (Trastuzumab) Sales Price by Application (2021-2026) & (US$/Unit) Table 153. North America Herceptin (Trastuzumab) Sales Price by Application (2027-2032) & (US$/Unit) Table 154. North America Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 156. North America Herceptin (Trastuzumab) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 157. North America Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 158. North America Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 159. North America Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 160. North America Herceptin (Trastuzumab) Sales Price by Country (2021-2026) & (US$/Unit) Table 161. North America Herceptin (Trastuzumab) Sales Price by Country (2027-2032) & (US$/Unit) Table 162. United States Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 163. Canada Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 164. Europe Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 165. Europe Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 166. Europe Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 167. Europe Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 168. Europe Herceptin (Trastuzumab) Sales Price by Type (2021-2026) & (US$/Unit) Table 169. Europe Herceptin (Trastuzumab) Sales Price by Type (2027-2032) & (US$/Unit) Table 170. Europe Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 171. Europe Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 172. Europe Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 173. Europe Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 174. Europe Herceptin (Trastuzumab) Sales Price by Application (2021-2026) & (US$/Unit) Table 175. Europe Herceptin (Trastuzumab) Sales Price by Application (2027-2032) & (US$/Unit) Table 176. Europe Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 177. Europe Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 178. Europe Herceptin (Trastuzumab) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 179. Europe Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 180. Europe Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 181. Europe Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 182. Europe Herceptin (Trastuzumab) Sales Price by Country (2021-2026) & (US$/Unit) Table 183. Europe Herceptin (Trastuzumab) Sales Price by Country (2027-2032) & (US$/Unit) Table 184. Germany Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 185. France Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 186. U.K. Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 187. Italy Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 188. Netherlands Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 189. China Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 190. China Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 191. China Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 192. China Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 193. China Herceptin (Trastuzumab) Sales Price by Type (2021-2026) & (US$/Unit) Table 194. China Herceptin (Trastuzumab) Sales Price by Type (2027-2032) & (US$/Unit) Table 195. China Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 196. China Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 197. China Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 198. China Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 199. China Herceptin (Trastuzumab) Sales Price by Application (2021-2026) & (US$/Unit) Table 200. China Herceptin (Trastuzumab) Sales Price by Application (2027-2032) & (US$/Unit) Table 201. Asia Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 202. Asia Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 203. Asia Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 204. Asia Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 205. Asia Herceptin (Trastuzumab) Sales Price by Type (2021-2026) & (US$/Unit) Table 206. Asia Herceptin (Trastuzumab) Sales Price by Type (2027-2032) & (US$/Unit) Table 207. Asia Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 208. Asia Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 209. Asia Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 210. Asia Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 211. Asia Herceptin (Trastuzumab) Sales Price by Application (2021-2026) & (US$/Unit) Table 212. Asia Herceptin (Trastuzumab) Sales Price by Application (2027-2032) & (US$/Unit) Table 213. Asia Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 214. Asia Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 215. Asia Herceptin (Trastuzumab) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 216. Asia Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 217. Asia Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 218. Asia Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 219. Asia Herceptin (Trastuzumab) Sales Price by Country (2021-2026) & (US$/Unit) Table 220. Asia Herceptin (Trastuzumab) Sales Price by Country (2027-2032) & (US$/Unit) Table 221. Japan Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 222. South Korea Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 223. India Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 224. Australia Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 225. China Taiwan Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 226. Southeast Asia Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 227. SAMEA Herceptin (Trastuzumab) Revenue by Type (2021-2026) & (US$ Million) Table 228. SAMEA Herceptin (Trastuzumab) Revenue by Type (2027-2032) & (US$ Million) Table 229. SAMEA Herceptin (Trastuzumab) Sales by Type (2021-2026) & (K Units) Table 230. SAMEA Herceptin (Trastuzumab) Sales by Type (2027-2032) & (K Units) Table 231. SAMEA Herceptin (Trastuzumab) Sales Price by Type (2021-2026) & (US$/Unit) Table 232. SAMEA Herceptin (Trastuzumab) Sales Price by Type (2027-2032) & (US$/Unit) Table 233. SAMEA Herceptin (Trastuzumab) Revenue by Application (2021-2026) & (US$ Million) Table 234. SAMEA Herceptin (Trastuzumab) Revenue by Application (2027-2032) & (US$ Million) Table 235. SAMEA Herceptin (Trastuzumab) Sales by Application (2021-2026) & (K Units) Table 236. SAMEA Herceptin (Trastuzumab) Sales by Application (2027-2032) & (K Units) Table 237. SAMEA Herceptin (Trastuzumab) Sales Price by Application (2021-2026) & (US$/Unit) Table 238. SAMEA Herceptin (Trastuzumab) Sales Price by Application (2027-2032) & (US$/Unit) Table 239. SAMEA Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 240. SAMEA Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 241. SAMEA Herceptin (Trastuzumab) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 242. SAMEA Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 243. SAMEA Herceptin (Trastuzumab) Sales by Country (2021-2026) & (K Units) Table 244. SAMEA Herceptin (Trastuzumab) Sales by Country (2027-2032) & (K Units) Table 245. SAMEA Herceptin (Trastuzumab) Sales Price by Country (2021-2026) & (US$/Unit) Table 246. SAMEA Herceptin (Trastuzumab) Sales Price by Country (2027-2032) & (US$/Unit) Table 247. Brazil Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 248. Argentina Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 249. Chile Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 250. Colombia Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 251. Peru Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 252. Saudi Arabia Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 253. Israel Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 254. UAE Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 255. Turkey Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 256. Iran Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 257. Egypt Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Table 258. Key Raw Materials Table 259. Raw Materials Key Suppliers Table 260. Herceptin (Trastuzumab) Distributors List Table 261. Herceptin (Trastuzumab) Customers List Table 262. Research Programs/Design for This Report Table 263. Authors List of This Report Table 264. Secondary Sources Table 265. Primary Sources List of Figures Figure 1. Herceptin (Trastuzumab) Image Figure 2. Global Herceptin (Trastuzumab) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herceptin (Trastuzumab) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Breast Cancer Image Figure 5. Stomach Cancer Image Figure 6. Others Image Figure 7. Global Herceptin (Trastuzumab) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Herceptin (Trastuzumab) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Medical Center Image Figure 11. Global Herceptin (Trastuzumab) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Herceptin (Trastuzumab) Revenue (2021-2032) & (US$ Million) Figure 13. Global Herceptin (Trastuzumab) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Herceptin (Trastuzumab) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Herceptin (Trastuzumab) Revenue Market Share by Region (2021-2032) Figure 16. Global Herceptin (Trastuzumab) Sales (2021-2032) & (K Units) Figure 17. Global Herceptin (Trastuzumab) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Herceptin (Trastuzumab) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Herceptin (Trastuzumab) Sales YoY (2021-2032) & (K Units) Figure 20. Europe Herceptin (Trastuzumab) Sales YoY (2021-2032) & (K Units) Figure 21. China Herceptin (Trastuzumab) Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Herceptin (Trastuzumab) Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Herceptin (Trastuzumab) Sales YoY (2021-2032) & (K Units) Figure 24. Global Herceptin (Trastuzumab) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Herceptin (Trastuzumab) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Herceptin (Trastuzumab) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Herceptin (Trastuzumab) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2032) Figure 30. Global Herceptin (Trastuzumab) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Herceptin (Trastuzumab) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2032) Figure 33. Global Herceptin (Trastuzumab) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Herceptin (Trastuzumab) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2032) Figure 36. Global Herceptin (Trastuzumab) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Herceptin (Trastuzumab) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2032) Figure 39. North America Herceptin (Trastuzumab) Revenue Share by Type (2021-2032) Figure 40. North America Herceptin (Trastuzumab) Sales Share by Type (2021-2032) Figure 41. North America Herceptin (Trastuzumab) Revenue Share by Application (2021-2032) Figure 42. North America Herceptin (Trastuzumab) Sales Share by Application (2021-2032) Figure 43. North America Herceptin (Trastuzumab) Revenue Share by Country (2021-2032) Figure 44. North America Herceptin (Trastuzumab) Sales Share by Country (2021-2032) Figure 45. Europe Herceptin (Trastuzumab) Revenue Share by Type (2021-2032) Figure 46. Europe Herceptin (Trastuzumab) Sales Share by Type (2021-2032) Figure 47. Europe Herceptin (Trastuzumab) Revenue Share by Application (2021-2032) Figure 48. Europe Herceptin (Trastuzumab) Sales Share by Application (2021-2032) Figure 49. Europe Herceptin (Trastuzumab) Revenue Share by Country (2021-2032) Figure 50. Europe Herceptin (Trastuzumab) Sales Share by Country (2021-2032) Figure 51. China Herceptin (Trastuzumab) Revenue Share by Type (2021-2032) Figure 52. China Herceptin (Trastuzumab) Sales Share by Type (2021-2032) Figure 53. China Herceptin (Trastuzumab) Revenue Share by Application (2021-2032) Figure 54. China Herceptin (Trastuzumab) Sales Share by Application (2021-2032) Figure 55. Asia Herceptin (Trastuzumab) Revenue Share by Type (2021-2032) Figure 56. Asia Herceptin (Trastuzumab) Sales Share by Type (2021-2032) Figure 57. Asia Herceptin (Trastuzumab) Revenue Share by Application (2021-2032) Figure 58. Asia Herceptin (Trastuzumab) Sales Share by Application (2021-2032) Figure 59. Asia Herceptin (Trastuzumab) Revenue Share by Country (2021-2032) Figure 60. Asia Herceptin (Trastuzumab) Sales Share by Country (2021-2032) Figure 61. SAMEA Herceptin (Trastuzumab) Revenue Share by Type (2021-2032) Figure 62. SAMEA Herceptin (Trastuzumab) Sales Share by Type (2021-2032) Figure 63. SAMEA Herceptin (Trastuzumab) Revenue Share by Application (2021-2032) Figure 64. SAMEA Herceptin (Trastuzumab) Sales Share by Application (2021-2032) Figure 65. SAMEA Herceptin (Trastuzumab) Revenue Share by Country (2021-2032) Figure 66. SAMEA Herceptin (Trastuzumab) Sales Share by Country (2021-2032) Figure 67. Herceptin (Trastuzumab) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Herceptin (Trastuzumab) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Breast Cancer
  • Stomach Cancer
  • Others
Applications
  • Hospital
  • Medical Center
Companies covered
  • Teva Pharmaceutical
  • Novartis AG
  • Merck
  • Mylan
  • Pfizer
  • Amgen
  • Samsung Bioepis
  • Roche Diagnostics
  • Mundipharma
  • Mabion
  • InvivoGen
  • Genentech
  • Celltrion
  • Bio-Techne
  • Biocon Limited
  • AryoGen Biopharma
  • Abnova Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Herceptin (Trastuzumab) Market by Type
  3. 1.2.1 Global Herceptin (Trastuzumab) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Breast Cancer
  5. 1.2.3 Stomach Cancer
  6. 1.2.4 Others
  7. 1.3 Herceptin (Trastuzumab) Market by Application
  8. 1.3.1 Global Herceptin (Trastuzumab) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Medical Center
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Herceptin (Trastuzumab) Market Dynamics
  1. 2.1 Herceptin (Trastuzumab) Industry Trends
  2. 2.2 Herceptin (Trastuzumab) Industry Drivers
  3. 2.3 Herceptin (Trastuzumab) Industry Opportunities and Challenges
  4. 2.4 Herceptin (Trastuzumab) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Herceptin (Trastuzumab) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Herceptin (Trastuzumab) Revenue by Region
  3. 3.2.1 Global Herceptin (Trastuzumab) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Herceptin (Trastuzumab) Revenue by Region (2021-2026)
  5. 3.2.3 Global Herceptin (Trastuzumab) Revenue by Region (2027-2032)
  6. 3.2.4 Global Herceptin (Trastuzumab) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Herceptin (Trastuzumab) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Herceptin (Trastuzumab) Sales by Region
  9. 3.4.1 Global Herceptin (Trastuzumab) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Herceptin (Trastuzumab) Sales by Region (2021-2026)
  11. 3.4.3 Global Herceptin (Trastuzumab) Sales by Region (2027-2032)
  12. 3.4.4 Global Herceptin (Trastuzumab) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Herceptin (Trastuzumab) Revenue by Manufacturers
  2. 4.1.1 Global Herceptin (Trastuzumab) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Herceptin (Trastuzumab) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Herceptin (Trastuzumab) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Herceptin (Trastuzumab) Sales by Manufacturers
  6. 4.2.1 Global Herceptin (Trastuzumab) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Herceptin (Trastuzumab) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Herceptin (Trastuzumab) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Herceptin (Trastuzumab) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Herceptin (Trastuzumab) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Herceptin (Trastuzumab) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Herceptin (Trastuzumab) Manufacturers, Product Type & Application
  13. 4.7 Global Herceptin (Trastuzumab) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Herceptin (Trastuzumab) Market CR5 and HHI
  16. 4.8.2 2025 Herceptin (Trastuzumab) Tier 1, Tier 2, and Tier 3
5 Herceptin (Trastuzumab) Market by Type
  1. 5.1 Global Herceptin (Trastuzumab) Revenue by Type
  2. 5.1.1 Global Herceptin (Trastuzumab) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Herceptin (Trastuzumab) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Herceptin (Trastuzumab) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Herceptin (Trastuzumab) Sales by Type
  6. 5.2.1 Global Herceptin (Trastuzumab) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Herceptin (Trastuzumab) Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Herceptin (Trastuzumab) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Herceptin (Trastuzumab) Price by Type
6 Herceptin (Trastuzumab) Market by Application
  1. 6.1 Global Herceptin (Trastuzumab) Revenue by Application
  2. 6.1.1 Global Herceptin (Trastuzumab) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Herceptin (Trastuzumab) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Herceptin (Trastuzumab) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Herceptin (Trastuzumab) Sales by Application
  6. 6.2.1 Global Herceptin (Trastuzumab) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Herceptin (Trastuzumab) Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Herceptin (Trastuzumab) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Herceptin (Trastuzumab) Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical
  2. 7.1.1 Teva Pharmaceutical Company Information
  3. 7.1.2 Teva Pharmaceutical Business Overview
  4. 7.1.3 Teva Pharmaceutical Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Herceptin (Trastuzumab) Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Recent Developments
  7. 7.2 Novartis AG
  8. 7.2.1 Novartis AG Company Information
  9. 7.2.2 Novartis AG Business Overview
  10. 7.2.3 Novartis AG Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis AG Herceptin (Trastuzumab) Product Portfolio
  12. 7.2.5 Novartis AG Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Herceptin (Trastuzumab) Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Mylan
  20. 7.4.1 Mylan Company Information
  21. 7.4.2 Mylan Business Overview
  22. 7.4.3 Mylan Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Mylan Herceptin (Trastuzumab) Product Portfolio
  24. 7.4.5 Mylan Recent Developments
  25. 7.5 Pfizer
  26. 7.5.1 Pfizer Company Information
  27. 7.5.2 Pfizer Business Overview
  28. 7.5.3 Pfizer Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Herceptin (Trastuzumab) Product Portfolio
  30. 7.5.5 Pfizer Recent Developments
  31. 7.6 Amgen
  32. 7.6.1 Amgen Company Information
  33. 7.6.2 Amgen Business Overview
  34. 7.6.3 Amgen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Amgen Herceptin (Trastuzumab) Product Portfolio
  36. 7.6.5 Amgen Recent Developments
  37. 7.7 Samsung Bioepis
  38. 7.7.1 Samsung Bioepis Company Information
  39. 7.7.2 Samsung Bioepis Business Overview
  40. 7.7.3 Samsung Bioepis Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Samsung Bioepis Herceptin (Trastuzumab) Product Portfolio
  42. 7.7.5 Samsung Bioepis Recent Developments
  43. 7.8 Roche Diagnostics
  44. 7.8.1 Roche Diagnostics Company Information
  45. 7.8.2 Roche Diagnostics Business Overview
  46. 7.8.3 Roche Diagnostics Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Roche Diagnostics Herceptin (Trastuzumab) Product Portfolio
  48. 7.8.5 Roche Diagnostics Recent Developments
  49. 7.9 Mundipharma
  50. 7.9.1 Mundipharma Company Information
  51. 7.9.2 Mundipharma Business Overview
  52. 7.9.3 Mundipharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Mundipharma Herceptin (Trastuzumab) Product Portfolio
  54. 7.9.5 Mundipharma Recent Developments
  55. 7.10 Mabion
  56. 7.10.1 Mabion Company Information
  57. 7.10.2 Mabion Business Overview
  58. 7.10.3 Mabion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mabion Herceptin (Trastuzumab) Product Portfolio
  60. 7.10.5 Mabion Recent Developments
  61. 7.11 InvivoGen
  62. 7.11.1 InvivoGen Company Information
  63. 7.11.2 InvivoGen Business Overview
  64. 7.11.3 InvivoGen Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 InvivoGen Herceptin (Trastuzumab) Product Portfolio
  66. 7.11.5 InvivoGen Recent Developments
  67. 7.12 Genentech
  68. 7.12.1 Genentech Company Information
  69. 7.12.2 Genentech Business Overview
  70. 7.12.3 Genentech Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Genentech Herceptin (Trastuzumab) Product Portfolio
  72. 7.12.5 Genentech Recent Developments
  73. 7.13 Celltrion
  74. 7.13.1 Celltrion Company Information
  75. 7.13.2 Celltrion Business Overview
  76. 7.13.3 Celltrion Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Celltrion Herceptin (Trastuzumab) Product Portfolio
  78. 7.13.5 Celltrion Recent Developments
  79. 7.14 Bio-Techne
  80. 7.14.1 Bio-Techne Company Information
  81. 7.14.2 Bio-Techne Business Overview
  82. 7.14.3 Bio-Techne Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bio-Techne Herceptin (Trastuzumab) Product Portfolio
  84. 7.14.5 Bio-Techne Recent Developments
  85. 7.15 Biocon Limited
  86. 7.15.1 Biocon Limited Company Information
  87. 7.15.2 Biocon Limited Business Overview
  88. 7.15.3 Biocon Limited Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Biocon Limited Herceptin (Trastuzumab) Product Portfolio
  90. 7.15.5 Biocon Limited Recent Developments
  91. 7.16 AryoGen Biopharma
  92. 7.16.1 AryoGen Biopharma Company Information
  93. 7.16.2 AryoGen Biopharma Business Overview
  94. 7.16.3 AryoGen Biopharma Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 AryoGen Biopharma Herceptin (Trastuzumab) Product Portfolio
  96. 7.16.5 AryoGen Biopharma Recent Developments
  97. 7.17 Abnova Corporation
  98. 7.17.1 Abnova Corporation Company Information
  99. 7.17.2 Abnova Corporation Business Overview
  100. 7.17.3 Abnova Corporation Herceptin (Trastuzumab) Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Abnova Corporation Herceptin (Trastuzumab) Product Portfolio
  102. 7.17.5 Abnova Corporation Recent Developments
8 North America
  1. 8.1 North America Herceptin (Trastuzumab) Market Size by Type
  2. 8.1.1 North America Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  3. 8.1.2 North America Herceptin (Trastuzumab) Sales by Type (2021-2032)
  4. 8.1.3 North America Herceptin (Trastuzumab) Price by Type (2021-2032)
  5. 8.2 North America Herceptin (Trastuzumab) Market Size by Application
  6. 8.2.1 North America Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  7. 8.2.2 North America Herceptin (Trastuzumab) Sales by Application (2021-2032)
  8. 8.2.3 North America Herceptin (Trastuzumab) Price by Application (2021-2032)
  9. 8.3 North America Herceptin (Trastuzumab) Market Size by Country
  10. 8.3.1 North America Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Herceptin (Trastuzumab) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Herceptin (Trastuzumab) Market Size by Type
  2. 9.1.1 Europe Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Herceptin (Trastuzumab) Sales by Type (2021-2032)
  4. 9.1.3 Europe Herceptin (Trastuzumab) Price by Type (2021-2032)
  5. 9.2 Europe Herceptin (Trastuzumab) Market Size by Application
  6. 9.2.1 Europe Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Herceptin (Trastuzumab) Sales by Application (2021-2032)
  8. 9.2.3 Europe Herceptin (Trastuzumab) Price by Application (2021-2032)
  9. 9.3 Europe Herceptin (Trastuzumab) Market Size by Country
  10. 9.3.1 Europe Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Herceptin (Trastuzumab) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Herceptin (Trastuzumab) Market Size by Type
  2. 10.1.1 China Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  3. 10.1.2 China Herceptin (Trastuzumab) Sales by Type (2021-2032)
  4. 10.1.3 China Herceptin (Trastuzumab) Price by Type (2021-2032)
  5. 10.2 China Herceptin (Trastuzumab) Market Size by Application
  6. 10.2.1 China Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  7. 10.2.2 China Herceptin (Trastuzumab) Sales by Application (2021-2032)
  8. 10.2.3 China Herceptin (Trastuzumab) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Herceptin (Trastuzumab) Market Size by Type
  2. 11.1.1 Asia Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Herceptin (Trastuzumab) Sales by Type (2021-2032)
  4. 11.1.3 Asia Herceptin (Trastuzumab) Price by Type (2021-2032)
  5. 11.2 Asia Herceptin (Trastuzumab) Market Size by Application
  6. 11.2.1 Asia Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Herceptin (Trastuzumab) Sales by Application (2021-2032)
  8. 11.2.3 Asia Herceptin (Trastuzumab) Price by Application (2021-2032)
  9. 11.3 Asia Herceptin (Trastuzumab) Market Size by Country
  10. 11.3.1 Asia Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Herceptin (Trastuzumab) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Herceptin (Trastuzumab) Market Size by Type
  2. 12.1.1 SAMEA Herceptin (Trastuzumab) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Herceptin (Trastuzumab) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Herceptin (Trastuzumab) Price by Type (2021-2032)
  5. 12.2 SAMEA Herceptin (Trastuzumab) Market Size by Application
  6. 12.2.1 SAMEA Herceptin (Trastuzumab) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Herceptin (Trastuzumab) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Herceptin (Trastuzumab) Price by Application (2021-2032)
  9. 12.3 SAMEA Herceptin (Trastuzumab) Market Size by Country
  10. 12.3.1 SAMEA Herceptin (Trastuzumab) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Herceptin (Trastuzumab) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Herceptin (Trastuzumab) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Herceptin (Trastuzumab) Value Chain Analysis
  2. 13.1.1 Herceptin (Trastuzumab) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Herceptin (Trastuzumab) Production Mode & Process
  6. 13.2 Herceptin (Trastuzumab) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Herceptin (Trastuzumab) Distributors
  9. 13.2.3 Herceptin (Trastuzumab) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst